Fidelity Investments’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Other funds holding TNYA
VCM
EAM
BGM
KCM
Fidelity Investments's TNYA Position: Q1 2026 in Review
Fidelity Investments reduced its Tenaya Therapeutics (TNYA) stake by 16% in Q1 2026, selling an estimated $337 and leaving 2,308 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5068.
Fidelity Investments first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $107M in Q4 2021. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.
- Fidelity Investments held 2,308 shares of Tenaya Therapeutics worth $1.6K as of Q1 2026.
- Fidelity Investments sold 456 Tenaya Therapeutics shares in Q1 2026, an estimated $337.
- Tenaya Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5068 holding.
- Fidelity Investments first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
- Fidelity Investments's Tenaya Therapeutics position peaked at $107M in Q4 2021.
- 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.